Detalles de la búsqueda
1.
A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer.
Br J Cancer
; 130(3): 450-456, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38110665
2.
Response to immune checkpoint inhibitor combination therapy in metastatic RET-mutated lung cancer from real-world retrospective data.
BMC Cancer
; 24(1): 178, 2024 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38317126
3.
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non-Small Cell Lung Cancer: The Neotorch Randomized Clinical Trial.
JAMA
; 331(3): 201-211, 2024 01 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38227033
4.
Results of the phase IIa study to evaluate the efficacy and safety of rezivertinib (BPI-7711) for the first-line treatment of locally advanced or metastatic/recurrent NSCLC patients with EGFR mutation from a phase I/IIa study.
BMC Med
; 21(1): 11, 2023 01 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36617560
5.
Efficacy and safety of combined immunotherapy and antiangiogenic therapy for advanced non-small cell lung cancer: a real-world observation study.
BMC Pulm Med
; 23(1): 175, 2023 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37208639
6.
Angstrom-scale ion channels towards single-ion selectivity.
Chem Soc Rev
; 51(6): 2224-2254, 2022 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35225300
7.
Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial.
Lancet Oncol
; 23(9): 1167-1179, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35908558
8.
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 23(6): 739-747, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35576956
9.
Highly Ion-Permselective Porous Organic Cage Membranes with Hierarchical Channels.
J Am Chem Soc
; 144(23): 10220-10229, 2022 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35586909
10.
On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial.
Mol Cancer
; 21(1): 4, 2022 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34980131
11.
Safety, antitumor activity and biomarkers of sugemalimab in Chinese patients with advanced solid tumors or lymphomas: results from the first-in-human phase 1 trial.
Cancer Immunol Immunother
; 71(8): 1897-1908, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34984540
12.
Camrelizumab in different PD-L1 expression cohorts of pre-treated advanced or metastatic non-small cell lung cancer: a phase II study.
Cancer Immunol Immunother
; 71(6): 1393-1402, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34668977
13.
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial.
JAMA
; 328(12): 1223-1232, 2022 09 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36166026
14.
Efficient metal ion sieving in rectifying subnanochannels enabled by metal-organic frameworks.
Nat Mater
; 19(7): 767-774, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32152561
15.
LINC01089 functions as a ceRNA for miR-152-3p to inhibit non-small lung cancer progression through regulating PTEN.
Cancer Cell Int
; 21(1): 143, 2021 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33653358
16.
Patients harboring uncommon EGFR exon 19 deletion-insertion mutations respond well to first-generation EGFR inhibitors and osimeritinib upon acquisition of T790M.
BMC Cancer
; 21(1): 1215, 2021 Nov 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34774017
17.
Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study.
Lancet Oncol
; 21(11): 1500-1512, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32966811
18.
Sulfonated Sub-1-nm Metal-Organic Framework Channels with Ultrahigh Proton Selectivity.
J Am Chem Soc
; 142(21): 9827-9833, 2020 05 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32364714
19.
Exosomal miR-126 blocks the development of non-small cell lung cancer through the inhibition of ITGA6.
Cancer Cell Int
; 20(1): 574, 2020 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33317527
20.
Efficient Gating of Ion Transport in Three-Dimensional Metal-Organic Framework Sub-Nanochannels with Confined Light-Responsive Azobenzene Molecules.
Angew Chem Int Ed Engl
; 59(31): 13051-13056, 2020 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32343468